These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 4667907)

  • 1. [Change in the blood coagulating and fibrinolytic systems in diabetic retinopathy and its treatment with anticoagulant and fibrinolytic preparations].
    Mikhaĭlova NA; Tartakovskaia AI
    Vestn Oftalmol; 1972; 5():88-91. PubMed ID: 4667907
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical basis for the control of anticoagulant and thrombolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):116-28. PubMed ID: 4098766
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis].
    Van de Loo J
    Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent aspects of the coagulation process, circumstances for its influencing by drugs].
    Montigel C
    Zentralbl Phlebol; 1968 Feb; 7(1):83-8. PubMed ID: 5682818
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coagulation and the fibrinolytic blood system in surgical patients with various lung and pleural diseases].
    Onushchenko BN; Kolesnikov IS; Pleshakov VT; Vikhriev BS; Sokolov SN; Klur BIu; Shcherba BV; Solov'eva OV
    Vestn Khir Im I I Grek; 1966 May; 96(5):51-4. PubMed ID: 6001202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced alterations of hemostasis and fibrinolysis.
    Fareed J; Hoppenstedt D; Bick RL; Bacher P
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1229-45. PubMed ID: 1452510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental validation of the use of alpha-adrenoblockers in combination with anticoagulants and fibrinolytic agents].
    Kalishevskaia TM; Golubeva MG; Bashkov GV
    Patol Fiziol Eksp Ter; 1988; (3):24-8. PubMed ID: 2902551
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies of anticoagulant and fibrinolytic effects of glyprolines Gly-Pro and Gly-Pro-Arg in conditions of immobilization stress].
    Grigor'eva ME; Liapina LA; Andreeva LA; Miasoedov NF
    Izv Akad Nauk Ser Biol; 2009; (5):585-90. PubMed ID: 19894599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cytochrome C, sulnate and contrical on a change in the blood coagulating system and fibrinolysis during blood flow recovery in ischemic extremities].
    Levandovskiĭ IV; Shal'nev AN
    Patol Fiziol Eksp Ter; 1979; (6):26-9. PubMed ID: 94430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood coagulation changes and pathogenesis of diabetic retinopathy. Recent advances].
    Porta M; Nuzzi R; Passera P
    Minerva Med; 1984 Oct; 75(41):2407-20. PubMed ID: 6390258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer, hemostasis and coaguloactive drugs].
    Nadiradze ISh
    Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coagulation problems and vascular purpuras].
    Mayall RC
    Rev Bras Med; 1966 May; 23(5):358-61. PubMed ID: 5943994
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with hemocoagulative and fibrinolytic equilibrium in coronary disease].
    Facchini G; Posteli T; Cremonini G; Bortolotti G; Addarii F
    Atti Soc Ital Cardiol; 1968; 2():122-3. PubMed ID: 5717486
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advantages and hazards of drug treatment in surgery. Anticoagulants and fibrinolytic agents].
    Gross R
    Chirurg; 1968 May; 39(5):201-8. PubMed ID: 4974339
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute thrombotic disorders.
    Kuntz JG; Cheesman JD; Powers RD
    Am J Emerg Med; 2006 Jul; 24(4):460-7. PubMed ID: 16787806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation disorders - recent lessons from clinical conditions.
    Scharf RE
    Hamostaseologie; 2015; 35(4):301-2. PubMed ID: 26536622
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic defibrination--a new principle of anticoagulant therapy].
    Voss D
    Internist (Berl); 1968 Sep; 9(9):389-90. PubMed ID: 4918659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.